Altor BioScience Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of immunotherapeutic agents for the treatment of cancer, viral infections, and autoimmune diseases. It offers STAR Fusion Reagents for diagnosing and targeting cancer and viral infections; and STAR Multimer Reagents for research and design of anti-cancer and anti-viral vaccine. The company's products in clinical stage include a monoclonal antibody that prevents and treats staphylococcal infections in premature neonates; and STAR-Ck or ALT-801, an anti-cancer drug. It also has products in various development stages, such as fusion agents for cancer and viral infections, immunotherapeutics against staphylococcal infections, gene therapy for cancer, and multimers reagents. In addition, the company provides products for detecting novel disease targets. Its products are used in the direct and quantitative detection of endogenous peptide antigens' presentation on diseased cells and tissues. The company was founded in 2002 and is headquartered in Miramar, Florida.

Contact Information

2810 North Commerce Parkway
Miramar Beach, FL 33025
United States



    Total FundingEmployeesLast Funding DateStatus

    Crunchbase Investment Rounds

    DateAmountRoundValuationLead InvestorOther Investors
    2011-01-19$10,300,000Series D
    2017-03-22$30,328,264Private Equity$309,000,000
    2009-10-21$1,189,045Series Unknown
    2010-03-29$647,000Debt Financing
    2013-03-21$5,500,000Private Equity
    2016-07-19$20,000,001Private Equity
    2010-07-26$1,625,000Series Unknown
    2005-03-11$1,090,000Series B
    2012-07-20$11,300,000Series Unknown
    2015-06-01$10,715,447Private Equity
    2007-04-25$15,000,000Series C
    2008-08-27$15,000,000Series C